CristinaMariaMerkhoferMDMHS

Oncology • Washington, DC

Head & Neck Cancer, Thoracic Cancer

Medical Oncologist

Join to view full profile

Dr. Merkhofer is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Merkhofer's full profile

Already have an account?

Office
1100 Irving St NW
Washington, DC 20010

Education & Training

University of WashingtonFellowship, Hematology and Medical Oncology, 2017 - 2020
UPMC Medical EducationResidency, Internal Medicine, 2014 - 2017
University of Wisconsin School of Medicine & Public HealthClass of 2014, MD
Johns Hopkins Bloomberg School of Public HealthMHS, International Health, Global Disease Epidemiology and Control, 2008 - 2010

Certifications & Licensure

MD State Medical License 2024 - 2025
WV State Medical License 2024 - 2025
DC State Medical License 2023 - 2024
WA State Medical License 2017 - 2024
PA State Medical License 2014 - 2017
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Medical Oncology

Publications & Presentations

PubMed

23 citations
HER2 in Non-Small Cell Lung Cancer: A Review of Emerging Therapies.
Natalie F Uy, Cristina M Merkhofer, Christina S Baik
Cancers. 2022-08-27
2 citations
Systemic Treatment Patterns and Outcomes in Patients With EGFR Mutated Non-small Cell Lung Cancer and Leptomeningeal Disease.
Cristina M Merkhofer, Boryana Eastman, Isabella Densmore, Lia M Halasz, Tresa McGranahan
Clinical Lung Cancer. 2022-07-01
1 citations
Effect of Clinical Trial Participation on Costs to Payers in Metastatic Non–Small-Cell Lung Cancer
Cristina Merkhofer, Shasank Chennupati, Qin Sun, Keith D. Eaton, Renato G. Martins
JCO Oncology Practice. 2021-08-10

Press Mentions

Clinical Trial Participation Studies Show Possible Survival Benefit, Misconceptions of Patient ConcernsSeptember 5th, 2019
Highlights from ASCO's Quality Care Symposium: A Clinical Trial May Offer the Best Survival Odds for People Battling Non-Small-Cell Lung Cancer, but Not Enough Patients Enroll in ThemSeptember 5th, 2019